Zelira Therapeutics Limited (ZLD)
CXA CXA Primary Summary
Zelira Therapeutics Limited (ZLD) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Zelira Therapeutics Limited ever had a stock split?
Zelira Therapeutics Limited Profile
| Biotechnology Industry | Healthcare Sector | Oludare Odumosu CEO | CXA Exchange | - ISIN |
| AU Country | 8 Employees | - Last Dividend | - Last Split | 28 Jul 2003 IPO Date |
Overview
Zelira Therapeutics Limited is a bio-pharmaceutical company that specializes in the research, development, and commercialization of cannabinoid-based medicines. The company has a focus on treating a wide range of medical conditions through its research and development efforts in Australia and the United States. The company was initially known as Zelda Therapeutics Limited but underwent a name change to Zelira Therapeutics Limited in December 2019. Since its inception in 2003, Zelira Therapeutics has established itself as a leader in cannabinoid-based therapies, boasting a diverse portfolio of products across various therapeutic areas. The company's headquarters are located in Perth, Australia, solidifying its presence both domestically and internationally.
Products and Services
- HOPE Brand Formulations
Zelira Therapeutics offers a range of cannabinoid-based formulations under the HOPE brand. These formulations are available in Australia, Washington, Pennsylvania, and Louisiana, designed to meet the needs of patients suffering from various medical conditions. The HOPE brand represents the company's commitment to providing innovative and effective treatments.
- Zenivol
Zenivol is a cannabinoid-based medicine developed by Zelira Therapeutics specifically for the treatment of chronic insomnia. This product signifies the company's effort to address a significant and often difficult-to-treat condition, showcasing their expertise in leveraging cannabinoids for therapeutic purposes.
- Over the Counter Products
Zelira Therapeutics also offers over-the-counter products, further expanding its reach beyond prescription medications. These include:
- SprinJene - An oral care product that combines the benefits of cannabinoids with traditional oral hygiene practices.
- RAF FIVE - A dermatology product designed to leverage the therapeutic properties of cannabinoids for skin health.
- Zyraydi - This product utilizes enhanced distillate capture and dissolution matrix technology, offering a novel approach to cannabinoid-based therapies.
